Item 5.07. Submission of Matters to a Vote of Security Holders.

On October 21, 2022, 9 Meters Biopharma, Inc. (the "Company") reconvened the Company's special meeting of stockholders (the "Special Meeting"), which was previously adjourned on September 23, 2022. At the close of business on July 25, 2022, the record date of the Special Meeting, the Company had 259,107,380 shares of common stock issued and outstanding. The holders of a total of 131,584,292 shares of common stock eligible to vote on the record date were present at the Special Meeting, either in person or by proxy, which constituted a quorum for the Special Meeting. At the Special Meeting, stockholders voted on the proposal to approve the potential issuance of shares the Company's common stock underlying secured convertible notes in an amount that may be equal to or exceed 20% of the Company's common stock outstanding, in order to comply with Nasdaq Listing Rule 5635(d). The final voting results for such proposal are set forth below:


  Votes For        Votes Against       Votes Abstained       Broker Non-Votes
 116,809,600        13,548,775            1,225,917                 --

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses